The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents

Vaccine

Volumn 29, Issue 4, 2011, Pages 650-659

  Eberly, Matthew D ^a   Gorman, Greg H ^a   Eide, Matilda B ^a   Olsen, Cara H ^b   Rajnik, Michael ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b USUHS   (United States)

Author keywords

Hospitalization; Rotavirus gastroenteritis; Rotavirus vaccine; Vaccine efficacy

Indexed keywords

ROTAVIRUS VACCINE;

ARMY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; GASTROENTERITIS; HOSPITALIZATION; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION;

CHILD, PRESCHOOL; FAMILY HEALTH; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNIZATION; INCIDENCE; INFANT; INFANT, NEWBORN; MILITARY PERSONNEL; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 78650563941     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.041     Document Type: Article

References (24)

1. Jin S., Kilgore P.E., Holman R.C., Clarke M.J., Gangarosa E.J., Glass R.I. Trends in hospitalizations for diarrhea in United States children from 1979 through 1992: estimates of the morbidity associated with rotavirus. Pediatr Infect Dis J 1996, 15:397-404.
2. Brandt C.D., Kim H.W., Rodriguez W.J., Arrobio J.O., Jeffries B.C., Stallings E.P., et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol 1983, 18:71-78.
3. Koopman J.S., Turkish V.J., Monto A.S., Gouvea V., Srivastava S., Isaacson R.E. Patterns and etiology of diarrhea in three clinical settings. Am J Epidemiol 1984, 119:114-123.
4. Matson D.O., Estes M.K. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis 1990, 162:598-604.
5. Parashar U.D., Alexander J.P., Glass R.I. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55:1-13.
6. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001, 344:564-572.
7. Department of Defense, Office of the Deputy Under Secretary of Defense for Military Community and Family Policy. Demographics report. Washington, DC: Department of Defense; 2007.
8. Wang F.T., Mast T.C., Glass R.J., Loughlin J., Seeger J.D. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010, 125(2):e208-213.
9. Boom J.A., Tate J.E., Sahni L.C., Rench M.A., Hull J.J., Gentsch J.R., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125(2):e199-207.
10. Hsu V.P., Staat M.A., Roberts N., Thieman C., Bernstein D.I., Ward R.L., et al. Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics 2005, 115:78-82.
11. Tate J.E., Panozzo C.A., Payne D.C., Patel M.M., Cortese M.M., Fowlkes A.L., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124:465-471.
12. Gentsch J.R., Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., et al. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis 2009, 200(Suppl. 1):S99-S105.
13. Linhares A.C., Velazquez F.R., Perez-Schael I., Saez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008, 371(9619):1181-1189.
14. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Eng J Med 2006, 354(1):23-33.
15. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Eng J Med 2006, 354(1):11-22.
16. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370(9601):1757-1763.
17. Gentsch J.R., Parashar U.D., Glass R.I. Impact of rotavirus vaccination: the importance of monitoring strains. Future Microbiol 2009, 4:1231-1234.
18. D'Souza R.M., Hall G., Becker N.G. Climatic factors associated with hospitalizations for rotavirus diarrhoea in children under 5 years of age. Epidemiol Infect 2008, 136:56-64.
19. Sattar S.A., Lloyd-Evans N., Springthorpe V.S., Nair R.C. Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg (Lond) 1986, 96:277-289.
20. Levy K., Hubbard A.E., Eisenberg J.N. Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis. Int J Epidemiol 2009, 38:1487-1496.
21. Haffejee I.E., Moosa A. Rotavirus studies in Indian (Asian) South African infants with acute gastroenteritis: I. Microbiological and epidemiological aspects. Ann Trop Paediatr 1990, 10:165-172.
22. Fine P.E. Herd immunity: history, theory, practice. Epidemiol Rev 1993, 15:265-302.
23. Rotavirus vaccination coverage among infants aged 5 months-immunization information system sentinel sites, United States, June 2006-June 2009. MMWR Morb Mortal Wkly Rep 2010, 59:521-524.
24. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008, 57:697-700.